Literature DB >> 17873551

Low-intensity exercise improves quality of life in patients with Crohn's disease.

Victor Ng1, Wanda Millard, Constance Lebrun, John Howard.   

Abstract

OBJECTIVE: This study examines the effects of a low-intensity walking program on the quality of life in patients with Crohn's disease.
DESIGN: Patients were randomized into exercise and nonexercise groups for a prospective study.
SETTING: Patients were recruited at the inflammatory bowel disease outpatient clinic at the London Health Science Center, London, Ontario. PATIENTS: Thirty-two adult patients met the inclusion criteria of (1) mildly active disease or disease in remission, (2) habitual physical activity of less than 2 times per week of vigorous activity, (3) not anticipating change of dose or type of medication for Crohn's disease, and (4) no history of cardiovascular disease. All 32 patients who entered the study completed the 3-month study. INTERVENTION: Patients performed low-intensity walking at an interval of 3 times per week for a duration of 3 months. Each walking session lasted for 30 minutes. MAIN OUTCOME MEASUREMENTS: The Inflammatory Bowel Disease Questionnaire, the Inflammatory Bowel Disease Stress Index, and the Harvey-Bradshaw Simple Index were used as outcome. Survey measurements were recorded at 1-month intervals on commencement of the walking program.
RESULTS: Patients in the exercise group experienced a statistically significant (P < 0.05) improvement in quality of life in all 3 of the outcome measurement questionnaires with no detrimental effects in terms of disease activity.
CONCLUSION: A low-intensity walking program may have a beneficial effect in patients with Crohn's disease and improve their quality of life with no exacerbations in disease symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17873551     DOI: 10.1097/JSM.0b013e31802b4fda

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  32 in total

1.  Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission.

Authors:  Patricia D Jones; Michael D Kappelman; Christopher F Martin; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

Review 2.  Exercise and inflammatory bowel disease.

Authors:  Neeraj Narula; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

Review 3.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

4.  Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors.

Authors:  Aamir N Dam; Adam M Berg; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 5.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

6.  Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease.

Authors:  Wolfgang Alexander Seeger; Juliane Thieringer; Philip Esters; Benjamin Allmendinger; Jürgen Stein; Hermann Schulze; Axel Dignass
Journal:  United European Gastroenterol J       Date:  2020-06-25       Impact factor: 4.623

7.  Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing.

Authors:  J M Otto; A F O'Doherty; P J Hennis; K Mitchell; J S Pate; J A Cooper; M P W Grocott; H E Montgomery
Journal:  Int J Colorectal Dis       Date:  2012-07-29       Impact factor: 2.571

8.  Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Saniya Tabani; Ryan U Warren; Paul J Christos; Brian P Bosworth; Ellen J Scherl
Journal:  Dig Dis Sci       Date:  2015-08-09       Impact factor: 3.199

9.  Influencing Factors of Inflammatory Bowel Disease-Fatigue: A Path Analysis Model.

Authors:  Suja P Davis; Ding-Geng Chen; Patricia B Crane; Linda P Bolin; Lee Ann Johnson; Millie D Long
Journal:  Nurs Res       Date:  2021 Jul-Aug 01       Impact factor: 2.381

Review 10.  The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Tony Long; Daniel van Langenberg
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.